Trade ANNX anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Annexon, Inc. (ANNX) is trading at US$4.97, down 5.33% today as of Aug 28, 16:00 EDT. The company has a market capitalisation of US$961.17M. Over the past 52 weeks, ANNX has traded between US$2.03 and US$7.18. On Syfe you can trade ANNX with $0 commission and add it to your watchlist.
| Previous close | US$5.25 |
|---|---|
| Market cap | US$961.17M |
| 52-week range | US$2.03 – US$7.18 |
| Volume | 1.62M |
| Exchange | US |
Add to Watchlist
Set Price Alert
Annexon, Inc.
Annexon, Inc. is a clinical-stage biopharmaceutical company, which develops a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, eye and brain. It offers drugs that control or target huntington’s and alzheimer’s disease, multiple sclerosis, glaucoma, parkinson’s disease, and spinal muscular atrophy. The company was founded by Ben Barres and Arnon Rosenthal on March 3, 2011 and is headquartered in Brisbane, CA.
Year: 2020
Annexon Insider Bought Shares Worth $3,319,019, According to a Recent SEC Filing
May 29, 9:29 PM · MT Newswires
Goldman Sachs Initiates Annexon at Neutral With $7 Price Target
May 12, 11:29 AM · MT Newswires
Annexon, Inc. (ANNX) stock is trading at US$4.97, -5.33% from the previous close of US$5.25.
The market cap for Annexon, Inc. (ANNX) stock is approximately US$961.17M.
The 52-week high for Annexon, Inc. (ANNX) stock is US$7.18.
The 52-week low for Annexon, Inc. (ANNX) stock is US$2.03.
Annexon, Inc. (ANNX) does not currently pay a dividend.
Stay on top of ANNX
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
